Related Experiment Video
Updated: May 23, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
Investigating paracetamol pharmacokinetics using venous and capillary blood and saliva sampling
Anneliese M Rittau1, Andrew J McLachlan
1Faculty of Pharmacy, University of Sydney and Centre for Education and Research on Ageing, Concord Repatriation General Hospital, Sydney, NSW, Australia.
Objective:
The aim of this study was to develop, validate and apply a high performance liquid chromatography (HPLC) assay for analysis of paracetamol, paracetamol glucuronide and paracetamol sulfate in plasma (venous and capillary) and saliva to study paracetamol pharmacokinetics in healthy volunteers.
Methods:
Samples were prepared using protein precipitation and analysed using reverse phase HPLC with UV detection. This assay was applied to venous and capillary plasma and saliva samples from 20 healthy volunteers after paracetamol 1g four times daily for three days.
Key Findings:
The HPLC assay for paracetamol and its metabolites was found to be sensitive and selective in plasma and saliva samples over the range 0.05-50 mg/l with an inter- and intraday precision and accuracy within 11.2% and 11.1%, respectively. Mean recoveries for all analytes were > 88%. A study of paracetamol pharmacokinetics in healthy volunteers found close agreement between the sampling matrices for paracetamol and metabolites (metabolites were not detected in saliva). The value for area under the concentration-time curve over the 6h dosing interval of venous plasma (45.3±12.9mg/l.h) was significantly higher than that observed for capillary plasma (33.8±12.9mg/l.h) or saliva (35.1±9.4mg/l.h; P>0.01).
Conclusions:
Capillary blood and saliva collection were found to be reliable sampling matrices for the evaluation of paracetamol pharmacokinetics, although paracetamol metabolites were not detected in saliva.
Related Concept Videos
Measurement of Bioavailability: Pharmacokinetic Methods
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Drug Concentrations: Measurements
Plasma —...
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's overall...
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
On...
Analysis of Population Pharmacokinetic Data
